Amoxicillin shortage reported

On local TV news just now.

Amoxicillin is an antibiotic.

We are primarily funded by readers. Please subscribe and donate to support us!


Three of the largest manufacturers of the common antibiotic amoxicillin are reporting supply concerns.

Hikma Pharmaceuticals, Teva Pharmaceutical Industries and Sandoz, the generics division of Novartis, have all reported shortages of various doses of the drug, which is most commonly used to treat bacterial infections in children.

Amoxicillin comes as a capsule, a tablet, a chewable tablet and as a liquid to be taken by mouth, depending on the age of the patient.

Most of the shortages were reported in the liquid form of the drug, which is used by young children, according to the University of Utah’s drug information service, which tracks medication shortages, though the database shows the companies reported limited supply of all the versions of the drug.

As of Oct. 25, the university’s drug tracker listed 14 of Hikma Pharmaceuticals’ amoxicillin products and nine products from Teva. The tracker listed 16 products from Sandoz as being in shortage.




Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.